Variables | 0 - 6 months after ART | 0 - 12 months after ART |
N = 669 | ||
Transfer out of studya | Transfer out: 43 (6%) | Transfer out: 64 (10%) |
Because of miscarriage | 14 (2%) | 15 (2%) |
Because of still birth | 12 (2%) | 17 (3%) |
Because of relocation | 7 (1%) | 14 (2%) |
Because of infant death | 7 (1%) | 11 (2%) |
Because of HIV DNA PCR positve infantb | 3 (<1%) | 6 (1%) |
Because of severe ART side effect | 0 | 1 (< 1%) |
Retention denominatorc | 626 | 605 |
Lost to follow up (LTFU) | LTFU: 45 (7%) | LTFU: 98 (15%) |
Voluntarily discontinued ART (voluntary withdrawal from study) | 9 (1%) | 21 (3%) |
Died | 6 (1%) | 10 (2%) |
Retained | 566 | 476 |
Retention (95% CI) | 90.4% (87.9 - 92.6) | 76.7% (75.2 - 81.9) |